1-http://new.who.int/news-room/fact-sheets/detail/obesity-and-overweight
2-Lysen LK, Israel DA. Nutrition in weight management. Krause’s food and the nutrition care process. 2012; 13:462-88.
3-Upadhyay J, Farr O, Perakakis N, Ghaly W, Mantzoros C. Obesity as a Disease. The Medical Clinics of North America. 2018 Jan;102(1):13-33. DOI: 10.1016/j.mcna.2017.08.004.
Top of Form
4-Haidari F, Samadi M, Mohammadshahi M, Jalali MT, Engali KA. Energy restriction combined with green coffee bean extract affects serum adipocytokines and the body composition in obese women. Asia Pac J Clin Nutr. 2017;26(6):1048-1054. doi:10.6133/apjcn.022017.03
5-Spinneker A, Sola R, Lemmen V, Castillo MJ, Pietrzik K, González-Gross M. Vitamin B6 status, deficiency and its consequences--an overview. Nutr Hosp. 2007;22(1):7-24.
6-Lee Gallagher M. The nutrients and their metabolism. Krause’s food and the nutrition care process. 2012; 13:74-88
7-Kleijnen J. Knipschild P. Niacin and vitamin B6 in mental functioning: a review of controlled trials in humans. Biol Psychiatry1991; 29:931-941.
8-Mikkelsen K, Stojanovska L, Prakash M, Apostolopoulos V. The effects of vitamin B on the immune/cytokine network and their involvement in depression. Maturitas. 2017 Feb 1; 96:58-71.
9-Konarzewska B, Stefańska E, Wendołowicz A, Cwalina U, Golonko A, Małus A, Kowzan U, Szulc A, Rudzki L, Ostrowska L. Visceral obesity in normal-weight patients suffering from chronic schizophrenia. BMC psychiatry. 2014 Dec; 14(1):35.
10-Lal, K.J.; Sharma, S.K.; Dakshinamurti, K. Regulation of calcium influx into vascular smooth muscle by vitamin B6. Clin. Exp. Hypertens. 1993, 15, 489–500.
11-Dakshinamurti, K.; Lal, K.J.; Ganguly, P.K. Hypertension, calcium channel and pyridoxine (vitamin B6). Mol. Cell Biochem. 1998, 188, 137–148.
12-Vasdev, S. Dietary vitamin B6 supplementation attenuates hypertension in spontaneously
hypertensive rats. Mol. Cell Biochem. 1999, 200, 155–162
13-Liu Z, Li P, Zhao ZH, Zhang Y, Ma ZM, Wang SX. Vitamin b6 prevents endothelial dysfunction, insulin resistance, and hepatic lipid accumulation in apoe −/− mice fed with high-fat diet. Journal of diabetes research. 2016; 2016.
14-Unoki-Kubota H, Yamagishi SI, Takeuchi M, Bujo H, Saito Y. Pyridoxamine, an inhibitor of advanced glycation end product (AGE) formation ameliorates insulin resistance in obese, type 2 diabetic mice. Protein and peptide letters. 2010 Sep 1; 17(9):1177-81.
15-Zemel MB, Bruckbauer A. Effects of a leucine and pyridoxine-containing nutraceutical on fat oxidation, and oxidative and inflammatory stress in overweight and obese subjects. Nutrients. 2012 Jun 15; 4(6):529-41.
16-Spellacy WN, Buhi WC, Birk SA. Vitamin B6 treatment of gestational diabetes mellitus: studies of blood glucose and plasma insulin. American journal of obstetrics and gynecology. 1977 Mar 15; 127(6):599-602.
17-de Gómez Dumm NT, Giammona AM, Touceda LA. Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine. Lipids in Health and Disease. 2003 Dec; 2(1):7.
18-Hlais S, Reslan DR, Sarieddine HK, Nasreddine L, Taan G, Azar S, Obeid OA. Effect of Lysine, Vitamin B6, and Carnitine Supplementation on the Lipid Profile of Male Patients With Hypertriglyceridemia: A 12-Week, Open-Label, Randomized, Placebo-Controlled Trial. Clinical therapeutics. 2012 Aug 1; 34(8):1674-82.
19-VIRK, RICKY S., et al. Effect of vitamin B-6 supplementation on fuels, catecholamines, and amino acids during exercise in men. Medicine and science in sports and exercise, 1999, 31.3: 400-408.
20-Tambasco-Studart M, Titiz O, Raschle T, Forster G, Amrhein N,Fitzpatrick TB (2005) Vitamin B6 biosynthesis in higher plants.Proc Natl Acad Sci U S A 102(38):13687–13692
21-Hagiwara S, Gohda T, Tanimoto M, Ito T, Murakoshi M, Ohara I, Yamazaki T, Matsumoto M, Horikoshi S, Funabiki K, Tomino Y. Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice. Metabolism-Clinical and Experimental. 2009 Jul 1; 58(7):934-45.
22-Abraham PM, Kuruvilla KP, Mathew J, Malat A, Joy S, Paulose CS. Alterations in hippocampal serotonergic and INSR function in streptozotocin induced diabetic rats exposed to stress: neuroprotective role of pyridoxine and Aegle marmelose. Journal of biomedical science. 2010 Dec; 17(1):78.
23-Wolin KY, Heil DP, Askew S, Matthews CE, Bennett GG. Validation of the International Physical Activity Questionnaire-Short among Blacks. J Phys Act Health. 2008; 5:746-60.
24-Amato MC, Giordano C. Visceral adiposity index: an indicator of adipose tissue dysfunction. Int J Endocrinol. 2014;2014(730827):14.
25-Chen Y, Zhang X, Pan B, Jin X, Yao H, Chen B, Zou Y, Ge J, Chen H. A modified formula for calculating lowdensitylipoprotein cholesterol values. Lipids in Health and Disease. 2010; 9:52.
26-Mahmoud AM, Ashour MB, Abdel-Moneim A, Ahmed OM. Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J Diabetes Complications 2012; 26:483-90.
27-D-A-CH: Reference values for nutrient intakes.Umschau/Braus. Pages. Frankfurt am Main. 1. ed. 2000.
28-Bear RL. Cutaneous skin changes probably due to pyridoxine abuse. J Am Acad Dermatol 1984; 10:527-528.
29-Food and Nutriton Board. Dietary reference intakes for thiamine, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. National Academy Press. Washington DC, 1998.
30-Zemel MB, Bruckbauer A. Effects of a leucine and pyridoxine-containing nutraceutical on body weight and composition in obese subjects. Diabetes Metab Syndr Obes. 2013;6:309-315. Published 2013 Aug 23. doi:10.2147/DMSO.S49623.
31-Zemel MB, Bruckbauer A. Effects of a leucine and pyridoxine-containing nutraceutical on fat oxidation, and oxidative and inflammatory stress in overweight and obese subjects. Nutrients. 2012; 4:529–541.
32-Xue B, Zemel M. Relationship between human adipose tissue agouti and fatty acid synthase (FAS). J Nutr. 2000; 130:2478–2481.
33- Kim JH, Kiefer LL, Woychik RP, Wilkison WO, Truesdale A, Ittoop O, Willard D, Nichols J, Zemel MB: Agouti regulation of intracellular calcium. Role of melanocortin receptor. Am J Physiol 272: E379–E384, 1997.
34-Xue B, Greenberg A, Kraemer F, Zemel M. Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes. FASEB J. 2001; 15:2527–2529.
35-Xue B. The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+-dependent mechanism. FASEB J. 1998; 12:1391–1396.
36-Shi H, Moustaid-Moussa N, Wilkison W, Zemel M. Role of the sulfonylurea receptor in regulating human adipocyte metabolism. FASEB J. 1999; 13:1833–1838.
37-Spellacy WN, Buhi WC, Birk SA. Vitamin B6 treatment of gestational diabetes mellitus: studies of blood glucose and plasma insulin. Am J Obstet Gynecol. 1977; 127(6):599‐602.
38-Tanimoto M, Gohda T, Kaneko S, Hagiwara S, Murakoshi M, Aoki T, et al. Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice. Metabolism 2007; 56:160-7.
39-Maessen DE, Brouwers O, Gaens KH, et al. Delayed Intervention With Pyridoxamine Improves Metabolic Function and Prevents Adipose Tissue Inflammation and Insulin Resistance in High-Fat Diet-Induced Obese Mice. Diabetes. 2016; 65(4):956‐966.